Home Journals Articles Updates About
CN
image
收藏切换
Low-Cost and Scalable Platform with Multiplexed Microwell Array Biochip for Rapid Diagnosis of COVID-19
收藏切换
PDF
Yang Wang1, Kaiju Li2, Gaolian Xu3, Chuan Chen2, Guiqin Song2, Zaizai Dong1, Long Lin1, Yu Wang2, Zhiyong Xu4, Mingxia Yu5, Xinge Yu6, Binwu Ying2, Yubo Fan1, Lingqian Chang1, Jia Geng2
Research. Vol 2021 Article ID 2813643
Less
收藏切换
Research. Vol 2021 Article ID 2813643
• Research Article •
Low-Cost and Scalable Platform with Multiplexed Microwell Array Biochip for Rapid Diagnosis of COVID-19
Full
Yang Wang1, Kaiju Li2, Gaolian Xu3, Chuan Chen2, Guiqin Song2, Zaizai Dong1, Long Lin1, Yu Wang2, Zhiyong Xu4, Mingxia Yu5, Xinge Yu6, Binwu Ying2, Yubo Fan1, Lingqian Chang1, Jia Geng2
Affiliations
  • 1Beijing Advanced Innovation Center for Biomedical Engineering, Key Laboratory for Biomechanics and Mechanobiology, School of Biological Science and Medical Engineering, Beihang University, Beijing 100083, China
  • 2Department of Laboratory Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu 610041, China
  • 3Nano Biomedical Research Centre, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China
  • 4Wuhan Chain Medical Labs, Wuhan, Hubei 430011 China
  • 5Department of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China
  • 6Department of Biomedical Engineering, City University of Hong Kong, China
About Author:

Authors’ Contributions

L. Chang and J. Geng coled the project, conceived the study, and provided guidance with experimental design. L. Chang and Y. Wang cowrote the paper. Y. Wang and G. Xu designed the experiments and analyzed the results. K. Li and C. Chen performed the experiments of clinical validation. G. Song, L. Lin, and Y. Wang contributed to the experimental setup. M. Yu provided the clinical samples. Z. Xu performed the RNA extraction experiment. X. Yu contributed to data analysis and provided advice on this work. Yang Wang, Kaiju Li, and Gaolian Xu contributed equally to this work. Kaiju Li and Gaolian Xu are co-first author.

Published: 2021-03-20 doi: 10.34133/2021/2813643
Outline
收藏切换

Sensitive detection of SARS-CoV-2 is of great importance for inhibiting the current pandemic of COVID-19. Here, we report a simple yet efficient platform integrating a portable and low-cost custom-made detector and a novel microwell array biochip for rapid and accurate detection of SARS-CoV-2. The instrument exhibits expedited amplification speed that enables colorimetric read-out within 25 minutes. A polymeric chip with a laser-engraved microwell array was developed to process the reaction between the primers and the respiratory swab RNA extracts, based on reverse transcriptase loop-mediated isothermal amplification (RT-LAMP). To achieve clinically acceptable performance, we synthesized a group of six primers to identify the conserved regions of the ORF1ab gene of SARS-CoV-2. Clinical trials were conducted with 87 PCR-positive and 43 PCR-negative patient samples. The platform demonstrated both high sensitivity (95.40%) and high specificity (95.35%), showing potentials for rapid and user-friendly diagnosis of COVID-19 among many other infectious pathogens.

Yang Wang, Kaiju Li, Gaolian Xu, Chuan Chen, Guiqin Song, Zaizai Dong, Long Lin, Yu Wang, Zhiyong Xu, Mingxia Yu, Xinge Yu, Binwu Ying, Yubo Fan, Lingqian Chang, Jia Geng. Low-Cost and Scalable Platform with Multiplexed Microwell Array Biochip for Rapid Diagnosis of COVID-19[J]. Research, 2021 , 2021 (3) : 2813643 - . DOI: 10.34133/2021/2813643
Full Text
Less
1. Introduction
Less
Coronavirus disease 2019 (COVID-19) has been a life-threatening pandemic caused by SARS-CoV-2 [1, 2]. It consists of four structural proteins and a single-stranded RNA as the genetic materials [3]. The rapid transmission of the virus among human beings has caused wide threats to the public health [4–8]. Up to August 23, 2020, the disease has spread to more than 200 countries, infected over 23.2 million people, and resulted in at least 800,000 deaths [9]. There is an urgent need on techniques for rapid and accurate detection of SARS-CoV-2 to inhibit its further spreading. Point-of-care testing (POCT) platforms with advantages of low-cost, easy operation, and high sensitivity/specificity are broadly applicable to daily life [10, 11].
The symptoms of the patients with the infection of COVID-19 are nonspecific, so various diagnostic methods have been developed accordingly [12–17]. To rapidly screen the subject infected with COVID-19, nucleic acid testing (NAT) based on the reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is now applied as a clinical-acceptable standard [18, 19]. Till now, RT-qPCR has been proved to be highly sensitive and specific [20, 21]. However, its dependence on expensive thermocycler and read-out systems limits the application, especially in some scenarios where the exponential increase of the infected patients exceeds the capacity of PCR instruments during the early outbreak of COVID-19 [22]. By contrast, isothermal amplification techniques conducted at fixed temperature do not rely on the expensive instruments for thermal cycling, thus offering the convenience for wide scopes, such as community hospitals, homes, or remote areas [23, 24]. Loop-mediated isothermal amplification (LAMP) is a low-cost yet rapid isothermal approach, which enables the identification of the target nucleic acid fragment of the virus within 1 hour, by using a set of primers and a strand-displacement polymerase at a constant temperature (60-65°C) [25–32]. To detect SARS-CoV-2, one type of RNA virus, reverse transcriptase (RT) is added in the LAMP system to initiate the amplification, known as RT-LAMP [33, 34]. The testing results can be visualized by adding a coupled pH indicator or a fluorescent dye in the reaction buffer [35, 36].
In this work, we developed a portable and scalable platform integrated with a multiplexed RT-LAMP microwell array biochip for rapid detection of SARS-CoV-2. The platform achieves full functions, including sample pretreatment, nucleic acid cleavage and enrichment, isothermal amplification, and colorimetric detection. On the platform, a simple laser-engraved microwell array chip was developed for multiplexed amplification of the viral RNA samples. We designed a group of six novel primers for specific identification of the conserved regions of the ORF1ab gene of SARS-CoV-2. To ascertain the rate of false results, both negative and positive controls were designed on the chip. A digital image sensing module and a liquid crystal display (LCD) were developed to detect the amplification results in each microwell. The platform achieved a low limit of detection of 1,000 copies/mL within 25 min for SARS-CoV-2 detection. Both high sensitivity (95.40%) and selectivity (95.35%) were achieved when applied this platform to test 130 clinical samples by double-blind testing at the West China Hospital, Chengdu, China. The overall performance of the platform proved its advantage as a portable and low-cost technique for rapid diagnosis of the infectious pathogens.
2. Results
Less
2.1. Basic Concept of the Point-of-Care Detection Platform
The setup of the platform and the microwell array-based RT-LAMP biochip is illustrated in Figure 1 (see Figure S1 for detailed circuit design and power delivery diagram). Four functional modules are designed and integrated on the platform, which implement the whole procedure including human throat swab sampling, RNA extraction, RT-LAMP amplification, and results reading (Figure 1(a), I to IV). During detection, the raw respiratory samples are collected with the aid of a swab and preserved in the sampling zone of the instrument, where the small tubes have been prefilled with virus preservation fluids. Subsequently, the collected samples are transferred with a three-channel pipette to the zone for viral inactivation and RNA extraction. The microwells prefilled with RT-LAMP buffer are applied to mix with the extracted RNAs, then initiate the isothermal amplification on the instrument under 60°C. Typically, a LAMP reaction experiences three steps, including “starting material producing step”, “cycling amplification step”, and “elongation and recycling step” [37]. A dumb-bell structure formed in the first step acts as the template for new DNA strand synthesis in the following two steps. In this work, for quick proof-of-concept, a polymethyl methacrylate (PMMA) chip with 5×1 microwells, including three for testing and two for control, was fabricated by laser engraving. Particularly, a conical-shaped microwell, with the top diameter of 500  μm and the bottom diameter of 3 mm, was adopted and designed (Figure 1(b), S3). The two external-control microwells are used to ascertain the rates of false-positive and false-negative results, further normalizing the output signal intensity across the devices for quantitative analysis. To achieve rapid and easy readout, we applied a colorimetric pH indicator (phenol red) in the reaction buffer. Once the amplification occurs, the pH variations lead to a color change of the buffer from pink to yellow. The color shift is proportional to the concentration of the target RNA [28]. The diagnostic result (i.e., positive (P) or negative (N) for SARS-CoV-2) in every microwell is scanned by a digital image sensor and is shown on a liquid crystal display (LCD) on the instrument. Notably, such a color change can also be visualized by the naked eye. Parameters of RT-LAMP settings, including reaction time and temperature, are set on the LCD (Figure S2).
The LAMP primers for detecting SARS-CoV-2 were designed based on the open reading frame 1ab (ORF1ab) gene, which was recommended by the Chinese Center for Disease Control and Prevention (CDC) [38]. We designed six novel specific primers, termed as inner primers (BIP and FIP), outer primers (B3 and F3), and loop primers (LoopF and LoopB) (Figure 1(c), see Table S1 for detailed sequences). The primers have obvious influences on the precise size of the amplification product during the cycling stage.
2.2. Optimizations for the LAMP Assay
To investigate the properties of different sets of designed primers (G1-G3), real-time RT-LAMP reactions were carried out. The results of negative reactions indicate that no nonspecific amplification occurred in the reactions, even with long incubation time up to 40 mins (Figure S4). More importantly, the results with a 10-fold serially diluted target ranging from 107 copies/mL to 109 copies/mL indicate that all sets of primers can be used for amplification and detection of the SARS-CoV-2. Compared with the other two sets of primers (G2 and G3), the threshold time (defined as the time corresponding to 50% of the maximum fluorescence intensity, Tt) needed for the nucleic acid amplification based on the first set of primer (G1) is relatively less, which means a faster reaction speed, especially for those targets with low concentrations (Figure 2(a)). Reaction temperature is another important factor for RT-LAMP amplification, which impacts not only the activity of the enzymes but also the hybridization capability and the efficiency between the primers and the target [39]. We optimized different reaction temperatures ranging from 50.6°C to 68.6°C for the RT-LAMP reaction and found out the amplification reached its best performance when the temperatures were 60.3°C and 62.6°C, respectively (Figure 2(b)). Considering the activity of RNA reverse transcriptase, we finally set the temperature on the instrument as 60°C for the amplification and detection.
2.3. Analytical Sensitivity of Real-Time LAMP
Various methods have been used for end-point analysis of the products from LAMP reactions, including gel electrophoresis, lateral flow immunoassay, turbidimetry, or pyrosequencing. However, these methods do not allow real-time detection and require further processing and instrumentation [40, 41]. Therefore, clinical trials of RT-LAMP reactions are commonly conducted on a PCR instrument because it can provide precise temperature control and real-time visualizing the amplification dynamics [42]. In this work, the sensitivity of the RT-LAMP assay was evaluated on both real-time PCR instrument and our portable instrument by using the first group of primers with different concentrations of ORF1ab gene plasmids ranging from 102 copies/mL to 109 copies/mL under 60°C. The results of real-time amplification performed on a PCR instrument indicate that the RT-LAMP system achieved the limit of detection (LOD) of 1,000 copies/mL for the SARS-CoV-2 within 40 min (Figure 3(a)). The corresponding Tt values of the RT-LAMP systems with triplicate measurements towards target concentrations from 109 copies/mL to 103 copies/mL are increased from 26 mins up to 51 mins (Figure 3(b)). Moreover, with the addition of different concentrations of plasmids into the microwells, a visible color was easily observed from pink to yellow, showing that the LOD of the portable detection system also achieves 1,000 copies/mL within 25 min from triplicate measurements (Figure S5).
Notably, the conical-shaped microwell demonstrated a faster read-out speed (~20 min) than commercial PCR tubes (>30 min) and the well of a 96-well plate (>60 min) on the instrument with a serially diluted target ranging from 105 copies/mL to 1011 copies/mL (Figure 3(d)). To investigate the reason, we modelled and simulated the heat transfer efficiency of the unique conical shape and the commercial tubes for RT-LAMP reaction by using COMSOL Multiphysics (Figure S6). The quantitative results show that the unique conical shape enables a faster heat transfer efficiency, resulting in a faster reaction speed than commercial tubes (Figure S7).
2.4. Clinical Validation
To validate the proposed system, double-blind, randomized controlled clinical trials were conducted at the West China Hospital, Chengdu, China, with 130 clinical samples that have been diagnosed by the RT-qPCR method. 87 samples were confirmed with SARS-CoV-2 infection and 43 negatives according to the RT-qPCR system (Table S2). The clinical samples were detected through RNA extraction and isothermal amplification based on the portable instrument (Figures 4(a)–4(d)). Both sensitivity and specificity of the platform were assessed. The sensitivity refers to its ability to correctly identify the patients infected with SARS-CoV-2 while the specificity refers to the ability to correctly identify the specimen without infections. The test outcomes were defined as true positive (TP), false positive (FP), true negative (TN), and false negative (FN). This platform exhibited both high sensitivity and high specificity of 95.40% and 95.35%, respectively, in terms of the diagnosis results (Figure 4(e)).
3. Discussion
Less
In this work, we implemented a portable and low-cost RT-LAMP platform for rapid diagnosis of COVID-19. The platform integrated full functions, including sample preservation, RNA extraction, thermal environment, and quantitative analysis. Containing a custom-made detection instrument and a low-cost microwell array biochip, it achieves high-throughput detection of SARS-CoV-2 RNAs from respiratory swab. We designed six novel primers for identifying the conserved regions of the ORF1ab gene of SARS-CoV-2. The RT-LAMP detection platform exhibited a low detection limit of 1,000 copies/mL with high specificity and high sensitivity, as validated with 130 clinical samples.
The total cost for fabricating the whole system was less than $600, including the detection instrument ($555.70) and microwell chip/primers ($1.57) (Table S3). For COVID-19 testing, the proposed portable instrument may find its suitability in some special scenarios, for example, customs and community hospitals, because of its advantages of low-cost (vs. PCR instruments) and rapid detection (25 min). In these scenarios, trained personnel would administer the test. We are currently developing a high throughput microwell chip that detects up to one hundred samples on one chip (Figure S8). Each microwell was marked on the left (row A-G) and above (column 1-14) to be easily addressed in testing procedure. Overall, the proposed platform offers both sensitivity and specificity that are comparable to RT-qPCR, yet with significantly lower cost, especially ideal for the regions with limited central laboratories, skilled personnel, and resources.
4. Materials and Methods
Less
4.1. Apparatus and Regents
All real-time RT-qPCR and RT-LAMP reactions were performed on a qPCR machine (Applied Biosystems® 7500, Thermo Fisher Scientific, UK). A single-sided MicroAmp® Optical Adhesive Film was purchased from Thermo Scientific. Polymethyl methacrylate (PMMA) plate was obtained from Wanglong Materials (Shenzhen, China). Three sets of LAMP primers were designed using LAMP primer software Primer Explorer V5 (http://primerexplorer.jp/e/intro/index.html; Eiken Chemical Co., Japan). For increasing the reliability of the results, we included the BRAC1 gene (see Table S2 for detailed sequences) as the positive control, which resulted in less possibilities of false-negative results [31]. All primers and plasmids were synthesized by Sangon Company (Shanghai, China). Extraction of RNA was based on a nucleic acid extraction kit (3DBiopharm, 20200219, China) and a nucleic acid isolation machine (3DBiopharm, NP968-C, China). All clinical samples were provided and tested at the West China Hospital, Chengdu, under the authorization of the Chinese CDC. The research on the multiplexed and point-of-care diagnosis of COVID-19 using clinical samples had been approved by the ethical committee at the West China Hospital, Chengdu, China (No. 2020 (267)).
4.2. Design and Fabrication of the Portable Instrument
The hardware block schematic of the custom-made device for point-of-care SARS-CoV-2 detection is shown in Figure S1. At the core of our system, we used an ARM STM32 microcontroller that could be programmed on-board through an in-circuit serial programming interface. The temperature sensor is designed to perceive the temperature of the instrument, whose specific values will be shown on the liquid crystal display. Once the temperature deviates from the set point, the corresponding drive circuit will be triggered to either heat up or cool down, thus maintaining a constant temperature. The liquid crystal display, with all sets, can realize the friendly man-machine interaction function. A digital camera and an algorithm for color intensity analysis were designed to accompany the portable instrument and to provide a user-friendly interface for data display on the LCD (Figure S2). During detection, the user will firstly turn on the instrument with a home page and a process of self-infection before work (Figure S2a). Subsequently, it will display the real-time status of the instrument (Figure S2b). Some amplification setups, including temperature and time, could be set through touch control (Figure S2c). Finally, the instrument enables the functions of LAMP reaction and detection. The data and graphs will be shown on the screen (Figure S2d). Moreover, they could be stored on the device.
4.3. Fabrication of Multiplexed Microwell Chip
The microwell chip was fabricated by etching conical wells into a 5 mm thick PMMA plate using the high precise 40 W CO2 Laser Engraver Machine Cutter (HPC Laser, Ltd.). The protocol utilizes laser cut with conditions of power: 30%, frequency: 2500 Hz, resolution: 1200 dpi, and programmed linewidth: 10  μm. The shapes of the conical wells, with the top diameter of 500  μm and the bottom diameter of 3 mm, were laser-machined by programming (Figure S3). We designed a single-row prototype of 5 microwells, whose total fabrication time was within 30 seconds. Moreover, a high throughput device with 100 microwells for simultaneous detection of 100 samples in one run was fabricated. A single-sided adhesive acetate film was used to seal plastic plate to form enclosed chambers for hosting the LAMP reaction and preventing the liquid from evaporation.
4.4. Real-Time RT-LAMP Reaction
The real-time RT-LAMP reactions were performed with the addition of the well-established fluorescent DNA-intercalating dye, SYBR@ Green, which is a green fluorescent nucleic acid dye and becomes highly fluorescent when it binds to dsDNA [43]. More importantly, this dye was readily compatible with real-time PCR instruments which were equipped with a 488 nm laser or any visible light excitation with a wavelength in the region. The RT-LAMP reaction was carried out using the WarmStart™ LAMP 2x Master Mix (DNA and RNA) from New England Biolabs (NEB). Typically, a final volume of 25  μL reaction mixture, which contained 12.5  μL of 2x Master Mix, 3.4  μL of primer mix, 0.5  μL of SYBR@ Green I, 5  μL of RNA target, and 3.6  μL of ddH2O, was mixed and used. The reaction buffer was optimized according to a previous study [30]. The LAMP reaction was run for 45 min at 60°C on a real-time PCR machine. The internal negative control was performed with the same composition with positive control but using ddH2O as the template.
4.5. RNA Extraction from Clinical Samples
RNA was extracted from throat swabs and blood samples collected from the patients with COVID-19 virus infection during the epidemic at the West China Hospital, Chengdu, in 2020. The respiratory specimens collected were firstly heated at 56°C for 30 min for inactivation. Subsequently, 300  μL of sample solutions were transferred into a nucleic acid extraction kit (3DBiopharm, 20200219, China), which was based on the method of magnetic beads in a biological safety cabinetry. After that, 20  μL of nucleic acid lyase was added to the above mixture. Finally, RNA was extracted by using a nucleic acid isolation machine (3DBiopharm, NP968-C, China) in about 26 min. To avoid the interference of TE buffer to RT-LAMP reaction, RNA extracts were eluted twice by RNase-free and DNase water.
4.6. RT-LAMP Assay on the Microwell Array Chip
After the extracted RNAs are transferred into the microwell, the upper side of the microwell is sealed with a single-sided adhesive film, forming an enclosed chamber for the isothermal amplification reaction. The RT-LAMP reaction on the multiplexed device was performed in a final volume of 25  μL, including 12.5  μL of WarmStart Colorimetric Lamp 2x Master Mix, 3.4  μL of primer mix, 0.5  μL of WarmStart™ colorimetric dye from NEB, 5  μL of RNA target, and 3.6  μL of ddH2O. The concentrations of the primers are 0.16  μM for the outer primers (B3 and F3), 0.8  μM for the inner primers (BIP and FIP), and 0.4  μM for the loop primers (LoopB and LoopF), respectively. RT-LAMP on the device was performed on the portable instrument at 60°C for 25 min. For detection of clinical samples, throat swab sampling, inactivation, and RNA extraction were performed based on corresponding functional zones integrated on the instrument. The extracted RNAs were transferred into the microwell chip and placed on the area labelled “Isothermal Amplification” on the instrument, which could complete the tests within 25 min.
4.7. Heat Transfer Simulation
To simulate the heat transfer efficiency, a multiphysics model was created on COMSOL Multiphysics software. The boundary conditions were provided as inputs to the model, and a convective heat flux form was selected with the following equation [44]:
(1)q0=hText−T
where h=10 W/(m2·K), Text=293.15 K, and T=333.15 K. The detailed boundary conditions were listed as follows: the thermal capacity at constant pressure was set as 1,464 J/(kg·K) and 385 J/(kg·K) for PMMA chips and reaction buffers, respectively; the thermal conductivity was set as 0.1 W/(m·K), 0.6 W/(m·K), and 400 W/(m·K) for PMMA chips, hot plate, and reaction buffer, respectively. The tangent coefficient of thermal expansion was set as 85 (1/K) for PMMA chips. According to the simulation results, the cloud images of temperature changes at key time nodes, including 1 s, 10s, 100 s, and 500 s were extracted.
Funding
Less
  • Beihang University
  • Natural Science Foundation of Shanghai(19ZR1476000)
  • Shanghai Municipal Education Commission(ZXWF082101/056)
  • 111 Project(B13003)
  • National Natural Science Foundation of China(62003023; 32071407)
  • Ministry of Education of the People's Republic of China
  • Special Research Funding on COVID-19 from Sichuan Province of China(2020YFS0004)
References
Less
1
Udugama B., Kadhiresan P., Kozlowski H. N., Malekjahani A., Osborne M., Li V. Y. C., Chen H., Mubareka S., Gubbay J. B., and Chan W. C. W., “Diagnosing COVID-19: the disease and tools for detection,” ACS Nano, vol. 14, no. 4, pp. 3822–3835, 2020
2
Murray M., Kenny E., Ritchie M., Rader D., Bale A., Giovanni M., and Abul-Husn N., “COVID-19 outcomes and the human genome,” Genetics in Medicine, vol. 22, no. 7, pp. 1175–1177, 2020
3
Long Q., Liu B., Deng H., Wu G., Deng K., Chen Y., Liao P., Qiu J., Lin Y., Cai X., Wang D., Hu Y., Ren J., Tang N., Xu Y., Yu L., Mo Z., Gong F., Zhang X., Tian W., Hu L., Zhang X., Xiang J., Du H., Liu H., Lang C., Luo X., Wu S., Cui X., Zhou Z., Zhu M., Wang J., Xue C., Li X., Wang L., Li Z., Wang K., Niu C., Yang Q., Tang X., Zhang Y., Liu X., Li J., Zhang D., Zhang F., Liu P., Yuan J., Li Q., Hu J., Chen J., and Huang A., “Antibody responses to SARS-CoV-2 in patients with COVID-19,” Nature Medicine, vol. 26, pp. 845–848, 2020
4
Chan J., Yuan S., Kok K., To K. K. W., Chu H., Yang J., Xing F., Liu J., Yip C., Poon R., Tsoi H., Lo S., Chan K., Poon V., Chan W., Ip J., Cai J., Cheng V., Chen H., Hui C., and Yuen K., “A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster,” Lancet, vol. 395, no. 10223, pp. 514–523, 2020
5
Gralnek I., Hassan C., and Dinis-Ribeiro M., “COVID-19 and endoscopy: implications for healthcare and digestive cancer screening,” Nature Reviews Gastroenterology & Hepatology, vol. 17, no. 8, pp. 444–446, 2020
6
Chen R., Liang W., Jiang M., Guan W., Zhan C., Wang T., Tang C., Sang L., Liu J., Ni Z., Hu Y., Liu L., Shan H., Lei C., Peng Y., Wei L., Liu Y., Hu Y., Peng P., Wang J., Liu J., Chen Z., Li G., Zheng Z., Qiu S., Luo J., Ye C., Zhu S., Liu X., Cheng L., Ye F., Zheng J., Zhang N., Li Y., He J., Li S., Zhong N., and Medical Treatment Expert Group for COVID-19, “Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China,” Chest, vol. 158, no. 1, pp. 97–105, 2020
7
Wu Y., Wang F., Shen C., Peng W., Li D., Zhao C., Li Z., Li S., Bi Y., Yang Y., Gong Y., Xiao H., Fan Z., Tan S., Wu G., Tan W., Lu X., Fan C., Wang Q., Liu Y., Zhang C., Qi J., Gao G. F., Gao F., and Liu L., “A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2,” Science, vol. 368, pp. 1274–1278, 2020
8
Morales-Narváez E., and Dincer C., “The impact of biosensing in a pandemic outbreak: COVID-19,” Biosensors & Bioelectronics, vol. 163, p. 112274, 2020
9
Le T., Andreadakis Z., Kumar A., Roman R., Tollefsen S., Saville M., and Mayhew S., “The COVID-19 vaccine development landscape,” Nature Reviews Drug Discovery, vol. 19, pp. 305–306, 2020
10
Seo G., Lee G., Kim M., Baek S., Choi M., Ku K., Lee C., Jun S., Park D., Kim H., Kim S., Lee J., Kim B., Park E. C., and Kim S., “Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor,” ACS Nano, vol. 14, no. 4, pp. 5135–5142, 2020
11
Mei X., Lee H., Diao K., Huang M., Lin B., Liu C., Xie Z., Ma Y., Robson P. M., Chung M., Bernheim A., Mani V., Calcagno C., Li K., Li S., Shan H., Lv J., Zhao T., Xia J., Long Q., Steinberger S., Jacobi A., Deyer T., Luksza M., Liu F., Little B. P., Fayad Z. A., and Yang Y., “Artificial intelligence-enabled rapid diagnosis of patients with COVID-19,” Nature Medicine, vol. 26, no. 8, pp. 1224–1228, 2020
12
Shen M., Zhou Y., Ye J., AL-maskri A. A., Kang Y., Zeng S., and Cai S., “Recent advances and perspectives of nucleic acid detection for coronavirus,” Journal of Pharmaceutical Analysis, vol. 10, no. 2, pp. 97–101, 2020
13
Chan J., Yip C., To K., Tang T., Wong S., Leung K., Fung A., Ng A., Zou Z., Tsoi H., Choi G., Tam A., Cheng V., Chan K., Tsang O., and Yuen K., “Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-PCR assay ValidatedIn Vitroand with clinical specimens,” Journal of Clinical Microbiology, vol. 58, no. 5, 2020
14
Broughton J., Deng X., Yu G., Fasching C., Servellita V., Singh J., Miao X., Streithorst J., Granados A., Sotomayor-Gonzalez A., Zorn K., Gopez A., Hsu E., Gu W., Miller S., Pan C., Guevara H., Wadford D., Chen J., and Chiu C., “CRISPR-Cas12-based detection of SARS-CoV-2,” Nature Biotechnology, vol. 38, no. 7, pp. 870–874, 2020
15
Joung J., Ladha A., Saito M., Kim N. G., Woolley A. E., Segel M., Barretto R. P. J., Ranu A., Macrae R. K., Faure G., Ioannidi E. I., Krajeski R. N., Bruneau R., Huang M. L. W., Yu X. G., Li J. Z., Walker B. D., Hung D. T., Greninger A. L., Jerome K. R., Gootenberg J. S., Abudayyeh O. O., and Zhang F., “Detection of SARS-CoV-2 with SHERLOCK one-pot testing,” The New England Journal of Medicine, vol. 383, no. 15, pp. 1492–1494, 2020
16
Dincer C., Bruch R., Kling A., Dittrich P., and Urban G., “Multiplexed point-of-care testing - xPOCT,” Trends in Biotechnology, vol. 35, no. 8, pp. 728–742, 2017
17
Nunez-Bajo E., Silva Pinto Collins A., Kasimatis M., Cotur Y., Asfour T., Tanriverdi U., Grell M., Kaisti M., Senesi G., Stevenson K., and Güder F., “Disposable silicon-based all-in-one micro-qPCR for rapid on-site detection of pathogens,” Nature Communications, vol. 11, no. 1, p. 6176, 2020
18
Corman V., Landt O., Kaiser M., Molenkamp R., Meijer A., Chu D., Bleicker T., Brünink S., Schneider J., Schmidt M., Mulders D., Haagmans B., van der Veer B., van den Brink S., Wijsman L., Goderski G., Romette J., Ellis J., Zambon M., Peiris M., Goossens H., Reusken C., Koopmans M., and Drosten C., “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR,” Euro Surveillance, vol. 25, article 2000045, 2020
19
Ai T., Yang Z., Hou H., Zhan C., Chen C., Lv W., Tao Q., Sun Z., and Xia L., “Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases,” Radiology, vol. 296, no. 2, pp. E32–E40, 2020
20
Won J., Lee S., Park M., Kim T., Park M., Choi B., Kim D., Chang H., Kim V., and Lee C., “Development of a laboratory-safe and low-cost detection protocol for SARS-CoV-2 of the coronavirus disease 2019 (COVID-19),” Experimental Neurobiology, vol. 29, no. 2, pp. 107–119, 2020
21
Ghosh S., Aggarwal K., Nguyen T., Han J., and Ahn C., “A new microchannel capillary flow assay (MCFA) platform with lyophilized chemiluminescence reagents for a smartphone-based POCT detecting malaria,” Microsystems & Nanoengineering, vol. 6, no. 1, p. 5, 2020
22
Lu R., Wu X., Wan Z., Li Y., Jin X., and Zhang C., “A novel reverse transcription loop-mediated isothermal amplification method for rapid detection of SARS-CoV-2,” International Journal of Molecular Sciences, vol. 21, no. 8, p. 2826, 2020
23
Nguyen T., Duong Bang D., and Wolff A., “2019 Novel coronavirus disease (COVID-19): paving the road for rapid detection and point-of-care diagnostics,” Micromachines, vol. 11, no. 3, p. 306, 2020
24
Yan C., Cui J., Huang L., Du B., Chen L., Xue G., Li S., Zhang W., Zhao L., Sun Y., Yao H., Li N., Zhao H., Feng Y., Liu S., Zhang Q., Liu D., and Yuan J., “Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay,” Clinical Microbiology and Infection, vol. 26, no. 6, pp. 773–779, 2020
25
Huang W., Lim B., Hsu C., Xiong D., Wu W., Yu Y., Jia H., Wang Y., Zeng Y., Ji M., Chang H., Zhang X., Wang H., and Cui Z., “RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2,” Microbial Biotechnology, vol. 13, no. 4, pp. 950–961, 2020
26
Park G., Ku K., Baek S., Kim S., Kim S., Kim B., and Maeng J., “Development of reverse transcription loop-mediated isothermal amplification assays targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),” The Journal of Molecular Diagnostics, vol. 22, no. 6, pp. 729–735, 2020
27
Yu L., Wu S., Hao X., Dong X., Mao L., Pelechano V., Chen W.-H., and Yin X., “Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform,” Clinical Chemistry, vol. 66, no. 7, pp. 975–977, 2020
28
Zhang Y., Odiwuor N., Xiong J., Sun L., Nyaruaba R., Wei H., and Tanner N., “Rapid molecular detection of SARS-CoV-2 (COVID-19) virus RNA using colorimetric LAMP,” medRxiv, 2020
29
Kashir J., and Yaqinuddin A., “Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19,” Medical Hypotheses, vol. 141, p. 109786, 2020
30
Xu G., Nolder D., Reboud J., Oguike M. C., van Schalkwyk D. A., Sutherland C. J., and Cooper J. M., “Paper-origami-based multiplexed malaria diagnostics from whole blood,” Angewandte Chemie International Edition, vol. 55, no. 49, pp. 15250–15253, 2016
31
Yang Z., Xu G., Reboud J., Ali S. A., Kaur G., McGiven J., Boby N., Gupta P. K., Chaudhuri P., and Cooper J. M., “Rapid veterinary diagnosis of bovine reproductive infectious diseases from semen using paper-origami DNA microfluidics,” ACS sensors, vol. 3, no. 2, pp. 403–409, 2018
32
Seok Y., Joung H., Byun J., Jeon H., Shin S., Kim S., Shin Y., Han H., and Kim M., “A paper-based device for performing loop-mediated isothermal amplification with real-time simultaneous detection of multiple DNA targets,” Theranostics, vol. 7, no. 8, pp. 2220–2230, 2017
33
Sun B., Shen F., McCalla S. E., Kreutz J. E., Karymov M. A., and Ismagilov R. F., “Mechanistic evaluation of the pros and cons of digital RT-LAMP for HIV-1 viral load quantification on a microfluidic device and improved efficiency via a two-step digital protocol,” Analytical Chemistry, vol. 85, no. 3, pp. 1540–1546, 2013
34
Priye A., Bird S., Light Y., Ball C., Negrete O., and Meagher R., “A smartphone-based diagnostic platform for rapid detection of Zika, chikungunya, and dengue viruses,” Scientific Reports, vol. 7, no. 1, article 44778, 2017
35
Ball C., Light Y., Koh C., Wheeler S., Coffey L., and Meagher R., “Quenching of unincorporated amplification signal reporters in reverse-transcription loop-mediated isothermal amplification enabling bright, single-step, closed-tube, and multiplexed detection of RNA viruses,” Analytical Chemistry, vol. 88, no. 7, pp. 3562–3568, 2016
36
Yao Y., Chen X., Zhang X., Liu Q., Zhu J., Zhao W., Liu S., and Sui G., “Rapid detection of influenza virus subtypes based on an integrated centrifugal disc,” ACS Sensors, vol. 5, no. 5, pp. 1354–1362, 2020
37
Notomi T., Okayama H., Masubuchi H., Yonekawa T., Watanabe K., Amino N., and Hase T., “Loop-mediated isothermal amplification of DNA,” Nucleic Acids Research, vol. 28, no. 12, article e63, 2000
38
Forster P., Forster L., Renfrew C., and Forster M., “Phylogenetic network analysis of SARS-CoV-2 genomes,” Proceedings of the National Academy of Sciences, vol. 117, no. 17, pp. 9241–9243, 2020
39
Rolando J., Jue E., Schoepp N., and Ismagilov R., “Real-time, digital LAMP with commercial microfluidic chips reveals the interplay of efficiency, speed, and background amplification as a function of reaction temperature and time,” Analytical Chemistry, vol. 91, no. 1, pp. 1034–1042, 2019
40
Tanner N., Zhang Y., and Evans T., “Simultaneous multiple target detection in real-time loop-mediated isothermal amplification,” BioTechniques, vol. 53, no. 2, pp. 81–89, 2012
41
Zhang X., Lowe S., and Gooding J., “Brief review of monitoring methods for loop-mediated isothermal amplification (LAMP),” Biosensors and Bioelectronics, vol. 61, pp. 491–499, 2014
42
Aoi Y., Hosogai M., and Tsuneda S., “Real-time quantitative LAMP (loop-mediated isothermal amplification of DNA) as a simple method for monitoring ammonia-oxidizing bacteria,” Journal of Biotechnology, vol. 125, no. 4, pp. 484–491, 2006
43
Zipper H., Brunner H., Bernhagen J., and Vitzthum F., “Investigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implications,” Nucleic Acids Research, vol. 32, no. 12, pp. e103–e103, 2004
44
Tan H., and Charters W., “Effect of thermal entrance region on turbulent forced-convective heat transfer for an asymmetrically heated rectangular duct with uniform heat flux,” Solar Energy, vol. 12, no. 4, pp. 513–516, 1969
Appendix
Less
Year 2021 volume 2021 Issue 3
PDF
58
33
Cite this Article
BibTeX
Article Info
doi: 10.34133/2021/2813643
  • Receive Date：2020-10-09
  • Online Date：2026-10-27
  • Published：2021-03-20
Article Data
Affiliations
History
  • Received：2020-10-09
  • Accepted：2021-01-31
Funding
Beihang University
Natural Science Foundation of Shanghai(19ZR1476000)
Shanghai Municipal Education Commission(ZXWF082101/056)
111 Project(B13003)
National Natural Science Foundation of China(62003023; 32071407)
Ministry of Education of the People's Republic of China
Special Research Funding on COVID-19 from Sichuan Province of China(2020YFS0004)
Affiliations
    1Beijing Advanced Innovation Center for Biomedical Engineering, Key Laboratory for Biomechanics and Mechanobiology, School of Biological Science and Medical Engineering, Beihang University, Beijing 100083, China
    2Department of Laboratory Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu 610041, China
    3Nano Biomedical Research Centre, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China
    4Wuhan Chain Medical Labs, Wuhan, Hubei 430011 China
    5Department of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China
    6Department of Biomedical Engineering, City University of Hong Kong, China
References
Share
https://castjournals.cast.org.cn/joweb/research/EN/10.34133/2021/2813643
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House